Cargando…
‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
Indispensable for shortening treatment of drug-susceptible tuberculosis (TB), pyrazinamide (PZA, Z) is also essential in the treatment of multidrug-resistant (MDR)-TB. While resistance to PZA in MDR-TB is associated with poor treatment outcome, bacillary susceptibility to PZA along with the use of f...
Autores principales: | Zhang, Ying, Chiu Chang, Kwok, Leung, Chi-Chiu, Wai Yew, Wing, Gicquel, Brigitte, Fallows, Dorothy, Kaplan, Gilla, Chaisson, Richard E, Zhang, Wenhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630910/ https://www.ncbi.nlm.nih.gov/pubmed/26038418 http://dx.doi.org/10.1038/emi.2012.18 |
Ejemplares similares
-
MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013) -
Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018) -
Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB
por: Bishai, Jason D., et al.
Publicado: (2010) -
Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013) -
MDR-TB in Pakistan: Challenges, efforts, and recommendations
por: Khan, Mahad Ahmed, et al.
Publicado: (2022)